• Dr. Roslyn Bernstein Mannon is a Professor of Medicine, Division of Nephrology and Professor of Surgery, Division of Transplantation at the University of Alabama at Birmingham and Director of Research for the Comprehensive Transplant Institute. She is the first Endowed Professor of Transplant Clinical Research at UAB and interim chief of transplant nephrology. She is a Fellow of the American Society of Nephrology and American Society of Transplantation. Dr. Mannon received her MD from Duke University School of Medicine. She completed her Internal Medicine internship, residency and Nephrology fellowship at Duke, and was Chief Medical Resident for the Department of Medicine. She remained on the faculty in the Division of Nephrology at Duke as an Assistant Professor of Medicine and Medical Director of the Durham VA Medical Center Kidney transplant program. In 2000, she joined the NIH/NIDDK intramural transplant program. There she served as the Medical Director of Kidney and Pancreas transplantation and was a primary investigator in intramural translational studies in tolerance and acute and late allograft failure. She joined UAB faculty in 2008, also serves as Medical Director of Transplantation at the Birmingham Veterans Affairs Medical Center. Dr. Mannon is a past-president of the American Society of Transplantation and is an Associate Editor for the American Journal of Transplantation and Journal of the American Society of Nephrology. Dr. Mannon is a board certified in internal medicine and nephrology. She has published over 100 peer reviewed publications on the mechanisms of chronic allograft injury, ischemic injury following organ procurement, and other medical complications after transplantation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient.Clinical Journal of the American Society of Nephrology2019
    2019 The Banff schema for antibody-mediated rejection: Lost in translation?American Journal of Transplantation.  19:9-10. 2019
    2018 The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.American Journal of Transplantation2018
    2018 Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.Kidney International.  94:1053-1068. 2018
    2018 Long-term follow-up of the DeKAF cross-sectional cohort study.American Journal of Transplantation2018
    2018 Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.Clinical Transplantation.  32:e13424. 2018
    2018 Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.American Journal of Transplantation2018
    2018 Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing.Pharmacogenomics Journal2018
    2018 The effect of renal transplantation on left ventricular function, electrocardiography, and mechanical synchrony by gated myocardial perfusion imaging.Journal of Nuclear Cardiology2018
    2018 Author Correction: Metformin reverses established lung fibrosis in a bleomycin model.Nature Medicine.  24:1627. 2018
    2018 Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation.American Journal of Transplantation.  18:2120-2134. 2018
    2018 Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation.American Journal of Transplantation.  18:2189-2199. 2018
    2018 Thrombotic Microangiopathy in a Transplant Recipient.Clinical Journal of the American Society of Nephrology.  13:1251-1253. 2018
    2018 Metformin reverses established lung fibrosis in a bleomycin model.Nature Medicine.  24:1121-1127. 2018
    2018 Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.American Journal of Transplantation.  18:1604-1614. 2018
    2018 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.Annals of Surgery.  267:1161-1168. 2018
    2018 NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD.Journal of the American Society of Nephrology.  29:1772-1779. 2018
    2018 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-Year Single-Center Experience.Annals of Surgery2018
    2018 Late graft failure after kidney transplantation as the consequence of late versus early events.American Journal of Transplantation.  18:1158-1167. 2018
    2018 Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report.Transplantation.  102:1358-1366. 2018
    2018 Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.Pharmacogenomics.  19:175-184. 2018
    2018 Delayed Graft Function: The AKI of Kidney Transplantation.Nephron.  140:94-98. 2018
    2017 The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.American Journal of Transplantation.  18:293-307. 2017
    2017 Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.Pharmacogenomics Journal.  18:501-505. 2017
    2017 Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.American Journal of Transplantation.  17:2851-2862. 2017
    2017 B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.American Journal of Transplantation.  17:2627-2639. 2017
    2017 Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.American Journal of Transplantation.  17:2712-2719. 2017
    2017 Cell-Free DNA and Active Rejection in Kidney Allografts.Journal of the American Society of Nephrology.  28:2221-2232. 2017
    2017 Access to Kidney Transplantation among HIV-Infected Waitlist Candidates.Clinical Journal of the American Society of Nephrology.  12:467-475. 2017
    2017 Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.Transplantation.  101:1527-1534. 2017
    2016 Obesity increases the risk of end-stage renal disease among living kidney donors.Kidney International.  91:699-703. 2016
    2016 Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys: A Randomized Controlled Trial.Transplantation.  101:1167-1176. 2016
    2016 Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.Clinical Infectious Diseases.  63:186-194. 2016
    2016 Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward.American Journal of Transplantation.  16:1094-1101. 2016
    2016 Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.American Journal of Transplantation.  16:574-582. 2016
    2015 Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.Pharmacogenomics Journal.  17:61-68. 2015
    2015 Hospital-onset Clostridium difficile infection among solid organ transplant recipients.American Journal of Transplantation.  15:2970-2977. 2015
    2015 Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected RecipientsAmerican Journal of Transplantation.  15:2096-2104. 2015
    2015 Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.American Journal of Transplantation.  15:2096-2104. 2015
    2015 The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?Current Transplantation Reports.  2:113-121. 2015
    2015 Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine.Transplantation reviews.  29:60-67. 2015
    2015 Identification of strategies to facilitate organ donation among African Americans using the nominal group technique.Clinical Journal of the American Society of Nephrology.  10:286-293. 2015
    2015 Cyclosporine-mediated allograft fibrosis is associated with micro-RNA-21 through AKT signaling.Transplant International.  28:232-245. 2015
    2015 Modernization of Chronic Allograft Injury Research: Better Biomarkers, Better Studies, Better Outcomes.Clinical Transplants.  31:211-225. 2015
    2015 Reduced PARP1 as a Serum Biomarker for Graft Rejection in Kidney Transplantation.Journal of Proteomics and Bioinformatics.  8:031-038. 2015
    2014 The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease.Journal of Nuclear Cardiology.  21:739-746. 2014
    2014 The microbiota, the immune system and the allograft.American Journal of Transplantation.  14:1236-1248. 2014
    2014 Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.Transplantation.  97:446-450. 2014
    2013 Necroptosis in solid organ transplantation: a missing link to immune activation?American Journal of Transplantation.  13:2785-2786. 2013
    2013 Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.Transplant International.  26:938-948. 2013
    2013 Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.American Journal of Transplantation.  13:1891-1897. 2013
    2012 A reproducible mouse model of chronic allograft nephropathy with vasculopathy.Kidney International.  82:1231-1235. 2012
    2012 Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.Transplantation.  94:971-977. 2012
    2012 A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011.Clinical Journal of the American Society of Nephrology.  7:1884-1889. 2012
    2012 Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation"Transplantation.  93. 2012
    2012 Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders?Current Opinion in Organ Transplantation.  17:20-25. 2012
    2011 Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.Transplantation.  92:1342-1347. 2011
    2011 Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.PROTEOMICS - Clinical Applications.  5:311-321. 2011
    2011 Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.Transplantation.  91:309-316. 2011
    2011 Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium.Transplantation.  91:300-308. 2011
    2011 Chemokines and their receptors in human renal allotransplantation.Transplantation.  91:70-77. 2011
    2011 Lack of renal dopamine D5 receptors promotes hypertension.Journal of the American Society of Nephrology.  22:82-89. 2011
    2010 Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.Nephrology Dialysis Transplantation.  25:4077-4086. 2010
    2010 Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study.Transplantation.  90:1099-1105. 2010
    2010 Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.Transplantation Proceedings.  42:3554-3558. 2010
    2010 Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.American Journal of Transplantation.  10:2066-2073. 2010
    2010 Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy.Journal of Molecular Diagnostics.  12:653-663. 2010
    2010 Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.Transplantation.  90:68-74. 2010
    2010 Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events.Clinical Transplantation.  24:557-563. 2010
    2010 Allograft fibrosis--unmasking the players at the dance.American Journal of Transplantation.  10:201-202. 2010
    2010 Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study.American Journal of Transplantation.  10:315-323. 2010
    2010 Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.American Journal of Transplantation.  10:324-330. 2010
    2009 Noninvasive methods to assess the risk of kidney transplant rejectionExpert Review of Clinical Immunology.  5:535-546. 2009
    2009 C3 polymorphisms and outcomes of renal allografts.New England Journal of Medicine.  360:2477-2478. 2009
    2008 Islet transplantation: need for a time-out?Nature Clinical Practice Nephrology.  4:660-661. 2008
    2008 Lymphocyte depletion for kidney transplantation: back to the past?Nature Clinical Practice Nephrology.  4:534-535. 2008
    2008 Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.American Journal of Transplantation.  8:1297-1302. 2008
    2008 Leflunomide therapy in kidney transplantation: ready for prime time?Clinical Journal of the American Society of Nephrology.  3:652-653. 2008
    2008 Obesity following kidney transplantation and steroid avoidance immunosuppression.Clinical Transplantation.  22:354-359. 2008
    2008 Therapeutic management of posttransplant diabetes mellitus.Transplantation reviews.  22:116-124. 2008
    2008 Care of the kidney transplant recipient.Clinical Journal of the American Society of Nephrology.  3 Suppl 2:S27-S28. 2008
    2008 Late kidney allograft loss: what we know about it, and what we can do about it.Clinical Journal of the American Society of Nephrology.  3 Suppl 2:S56-S67. 2008
    2008 Monocyte infiltration and kidney allograft dysfunction during acute rejection.American Journal of Transplantation.  8:600-607. 2008
    2007 Diagnostic tools for monitoring kidney transplant recipients.Seminars in Nephrology.  27:462-478. 2007
    2006 Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis.American Journal of Transplantation.  6:2292-2306. 2006
    2006 Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay.Transplantation.  82:663-668. 2006
    2006 Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.American Journal of Transplantation.  6:1084-1085. 2006
    2006 Beyond histology: novel tools to diagnose allograft dysfunction.Clinical Journal of the American Society of Nephrology.  1:358-366. 2006
    2006 Therapeutic targets in the treatment of allograft fibrosis.American Journal of Transplantation.  6:867-875. 2006
    2006 Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.Journal of Clinical Investigation.  116:769-774. 2006
    2006 Successful renal transplantation in patients with chronic granulomatous disease.American Journal of Transplantation.  6:636-639. 2006
    2005 Molecular evaluation of BK polyomavirus nephropathy.American Journal of Transplantation.  5:2883-2893. 2005
    2005 Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.Transplantation.  80:1051-1059. 2005
    2005 Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature.Pediatric Transplantation.  9:545-550. 2005
    2005 Detection and localization of proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325.Journal of the American Society of Nephrology.  16:1752-1757. 2005
    2005 First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.Pediatric Nephrology.  20:452-454. 2005
    2005 Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy.Journal of The American College of Surgeons.  200:552-556. 2005
    2005 Functionally significant renal allograft rejection is defined by transcriptional criteria.American Journal of Transplantation.  5:573-581. 2005
    2005 Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.American Journal of Transplantation.  5:465-474. 2005
    2005 Solid organ transplantation at the National Institutes of Health: development of a research-based transplantation practice.Clinical Transplants.  131-144. 2005
    2005 Strategies for minimizing immunosuppression in kidney transplantation.Transplant International.  18:2-14. 2005
    2004 Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy.Kidney International.  66:1686-1693. 2004
    2004 The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.Transplant Immunology.  13:87-99. 2004
    2004 Polyomavirus nephropathy: what have we learned?Transplantation.  77:1313-1318. 2004
    2004 The clinical application of monoclonal antibody therapies in renal transplantation.Expert Opinion on Emerging Drugs.  9:23-37. 2004
    2004 Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report.American Journal of Transplantation.  4:447-449. 2004
    2003 Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).Transplantation.  76:120-129. 2003
    2003 Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation.Surgery.  133:438-439. 2003
    2003 Inhibition of prolyl-4-hydroxylase ameliorates chronic rejection of mouse kidney allografts.American Journal of Transplantation.  3:396-402. 2003
    2003 Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy.Lancet.  361:969. 2003
    2003 Immunologic monitoring of the transplant recipient: Challenges and approaches with antibody inductionTransplantation reviews.  17. 2003
    2002 BK virus and SV40 co-infection in polyomavirus nephropathy.Transplantation.  74:1497-1504. 2002
    2002 Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.Lancet.  360:1662-1664. 2002
    2002 Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury.Transplantation.  74:916-923. 2002
    2002 Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection.Kidney International.  62:290-300. 2002
    2001 Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice.Journal of Immunology.  167:6631-6636. 2001
    2001 Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.Journal of Clinical Investigation.  108:1229-1235. 2001
    2000 Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.Transplantation.  69:2137-2143. 2000
    2000 Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.Cellular Immunology.  201:14-21. 2000
    2000 Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.Transplantation.  69:399-405. 2000
    1999 Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.Journal of Clinical Investigation.  104:1693-1701. 1999
    1999 Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection.The Journal of heart transplantation.  18:819-827. 1999
    1999 Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon.Regulatory Peptides.  83:11-19. 1999
    1999 Gene targeting: applications in transplantation research.Kidney International.  56:18-27. 1999
    1999 Chronic rejection of mouse kidney allografts.Kidney International.  55:1935-1944. 1999
    1998 Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.Journal of Clinical Investigation.  102:1994-2001. 1998
    1998 Immune cells in a mouse airway model of obliterative bronchiolitis.American Journal of Respiratory Cell and Molecular Biology.  19:379-386. 1998
    1998 Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells.American Journal of Physiology.  275:F262-F269. 1998
    1998 Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cellsAJP - Renal Physiology.  275. 1998
    1998 Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.Journal of Clinical Investigation.  101:2517-2527. 1998
    1996 Distribution of binding sites for thromboxane A2 in the mouse kidney.American Journal of Physiology.  271:F1131-F1138. 1996
    1996 Distribution of binding sites for thromboxane a2 in the mouse kidneyAmerican Journal of Physiology.  271. 1996
    1996 The intragraft CD8+ T cell response in renal allograft rejection in the mouse.Transplantation.  62:96-104. 1996
    1995 Rejection of kidney allografts by MHC class I-deficient mice.Transplantation.  59:746-755. 1995
    1994 Management of hypertensive emergencies and urgencies.North Carolina Medical Journal.  55:295-303. 1994
    1993 Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa.Southern Medical Journal.  86:1400-1402. 1993
    1993 Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone.Transplantation.  56:1157-1162. 1993
    1992 Immunologic mechanisms of transplant rejection.Current Opinion in Nephrology and Hypertension.  1:230-235. 1992


    Year Title Altmetric
    2015 Organ-specific features in clinical transplantation.  217-236. 2015

    Research Overview

  • Late kidney allograft failure, the leading cause of late graft loss, is the focus of our research. Through clinical, translational and basic science studies, we are evaluating the etiologies of this disorder in the hopes of identifying biomarkers and potential therapeutic targets in our patient population.
  • Principal Investigator On

  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research - Core A  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Private Grant  awarded by CSL BEHRING, LLC 2017 - 2022
  • Private Grant  awarded by MALLINCKRODT, INC. 2017 - 2022
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco 2014 - 2021
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2020
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco 2016 - 2020
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2019
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC. 2017 - 2019
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2013 - 2017
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton 2015 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Genomics of Kidney Transplantation Admin  awarded by University of Minnesota 2011 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2016
  • Private Grant  awarded by TRANSPLANT INFORMATICS INSTITUTE 2011 - 2015
  • Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors  awarded by Northwestern University 2012 - 2014
  • The Collaborative Network for Clinical Research in Immune Tolerance  awarded by University of California, San Francisco 2010 - 2014
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014
  • Private Grant  awarded by AMGEN, INC. 2010 - 2014
  • Individualizing Therapy for Kidney and Heart Transplant Recipients  awarded by MT. SINAI MEDICAL CENTER 2010 - 2012
  • Genomics of Kidney Transplantation  awarded by University of Minnesota 2009 - 2011
  • Investigator On

  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2025
  • UAB-UCSD O'Brien Center For Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • RXR Rexinoids for Cancer Chemoprevention  awarded by National Cancer Institute/NIH/DHHS 2017 - 2022
  • RXR Rexinoids for Cancer Chemoprevention - Project 1: Evaluation if UAB30 on Skin Cancer Biomarkers in Human Renal Transplant Recipients  awarded by National Cancer Institute/NIH/DHHS 2017 - 2022
  • APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by CAREDX INC. 2015 - 2020
  • Long-Term Outcomes Among Living Kidney Donors with Isolated Medical Abnormalities  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2015 - 2020
  • Novel Biomarkers of Angiogenesis and Vascular Injury in Chronic Rejection  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2015 - 2019
  • Prospective Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients  awarded by Johns Hopkins University 2018 - 2019
  • Early Life Stress and Cardio-renal Disease in Kidney Transplantation  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2017 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Immunosuppression and Risk Prediction of Sepsis after Solid Organ Transplantation  awarded by National Institute of General Medical Sciences/NIH/DHHS 2017 - 2018
  • The Role of Heme Oxygenase-1 in the Immune Response  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2011 - 2016
  • Education And Training

  • Doctor of Medicine, Duke University
  • Full Name

  • Roslyn Mannon